Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Wisconsin School of Medicine and Public Health, Madison, WI, United States.
Gynecol Oncol. 2017 Apr;145(1):114-121. doi: 10.1016/j.ygyno.2017.01.024. Epub 2017 Feb 1.
To examine patterns of care and survival for Hispanic women compared to white and African American women with high-grade endometrial cancer.
We utilized the National Cancer Data Base (NCDB) to identify women diagnosed with uterine grade 3 endometrioid adenocarcinoma, carcinosarcoma, clear cell carcinoma and papillary serous carcinoma between 2003 and 2011. The effect of treatment on survival was analyzed using the Kaplan-Meier method. Factors predictive of outcome were compared using the Cox proportional hazards model.
43,950 women were eligible. African American and Hispanic women had higher rates of stage III and IV disease compared to white women (36.5% vs. 36% vs. 33.5%, p<0.001). African American women were less likely to undergo surgical treatment for their cancer (85.2% vs. 89.8% vs. 87.5%, p<0.001) and were more likely to receive chemotherapy (36.8% vs. 32.4% vs. 32%, p<0.001) compared to white and Hispanic women. Over the entire study period, after adjusting for age, time period of diagnosis, region of the country, urban or rural setting, treating facility type, socioeconomic status, education, insurance, comorbidity index, pathologic stage, histology, lymphadenectomy and adjuvant treatment, African American women had lower overall survival compared to white women (Hazard Ratio 1.21, 95% CI 1.16-1.26). Conversely, Hispanic women had improved overall survival compared to white women after controlling for the aforementioned factors (HR 0.87, 95% CI 0.80-0.93).
Among women with high-grade endometrial cancer, African American women have lower all-cause survival while Hispanic women have higher all-cause survival compared to white women after controlling for treatment, sociodemographic, comorbidity and histopathologic variables.
研究与白人及非裔美国女性相比,西班牙裔女性在患有高级别子宫内膜癌时的治疗模式和生存情况。
我们利用国家癌症数据库(NCDB),在 2003 年至 2011 年间,确定了患有子宫 3 级子宫内膜样腺癌、癌肉瘤、透明细胞癌和乳头状浆液性癌的女性。使用 Kaplan-Meier 方法分析治疗对生存的影响。使用 Cox 比例风险模型比较预测结果的因素。
共有 43950 名女性符合条件。非裔美国女性和西班牙裔女性的 III 期和 IV 期疾病发生率高于白人女性(36.5%比 36%比 33.5%,p<0.001)。非裔美国女性接受癌症手术治疗的比例较低(85.2%比 89.8%比 87.5%,p<0.001),接受化疗的比例较高(36.8%比 32.4%比 32%,p<0.001),与白人及西班牙裔女性相比。在整个研究期间,在校正年龄、诊断时间、国家地区、城乡环境、治疗设施类型、社会经济地位、教育程度、保险、合并症指数、病理分期、组织学、淋巴结切除术和辅助治疗后,非裔美国女性的总体生存率低于白人女性(风险比 1.21,95%置信区间 1.16-1.26)。相反,在控制了上述因素后,西班牙裔女性的总体生存率高于白人女性(HR 0.87,95%CI 0.80-0.93)。
在患有高级别子宫内膜癌的女性中,非裔美国女性的全因生存率较低,而西班牙裔女性的全因生存率较高,与白人女性相比,在控制治疗、社会人口学、合并症和组织病理学变量后。